[精品][經(jīng)典]調(diào)脂湯治療非酒精性脂肪肝臨床療效觀察.doc

《[精品][經(jīng)典]調(diào)脂湯治療非酒精性脂肪肝臨床療效觀察.doc》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在工程資料-天天文庫。

1、[經(jīng)典]調(diào)脂湯治療非酒精性脂肪肝臨床療效觀察調(diào)脂湯治療非酒精性脂肪肝臨床療效觀察【摘?！磕康模禾接懻{(diào)脂湯治療非酒精性脂肪肝的臨床療效。方法：按診斷標(biāo)準(zhǔn)選擇非酒精性脂肪肝患者162例，隨機(jī)分為兩組，治療組、對(duì)照組各81例。治療組服用調(diào)脂湯；對(duì)照組服用東寶肝泰片，治療前后詳細(xì)記錄兩組患者評(píng)定指標(biāo),實(shí)驗(yàn)完成后對(duì)數(shù)據(jù)進(jìn)行整理分析。結(jié)果：治療組總體療效優(yōu)于對(duì)照組，兩組比較卩V0.05,差異有顯著性意義。其中，在降血脂方面，兩組治療前后組內(nèi)比較具有明顯差異，PV0.05；但治療后兩組間比較無明顯差異，P>0.05；在改善肝功能方面，兩者血清ALT、AST下降存在明顯差異，P<0.05o結(jié)論：調(diào)

2、脂湯治療非酒精性脂肪肝療效明顯優(yōu)于東寶肝泰片，其機(jī)理可能是通過改善肝細(xì)胞功能及降血脂實(shí)現(xiàn)的。【關(guān)鍵詞】非酒精性脂肪肝；調(diào)脂湯TheobservingofclinicaleffectofTiaoZhiSouptreatingwithnon-alcoholicfatty1iverdisease?Auther:MiaoXiangdong;Correspond!ng:FuHuaicheng(HezeChinesemedicinehospitalShandongProvinceHeze274000)[Abstract]Goal:ToexploretheclinicaleffectofTiao

3、ZhiSoupontreatingthenon-alcoholicfattyliverdisease?Method:Accordingtothediagnosisstandard,choosingthenon-alcoholicfatty1iverpatient162examplesaltogether?Thepatientswererandomlydividedintotwogroups:Thetreatmentgroupandthecontrolgroup.Eachgrouphave81examples.ThetreatmentgroupwastreatedwithTiaoZh

4、iSoupandthecontrolgroupwastreatedwithDongbaoLiverPiece?Aroundthetreatment,therelatedindicatorsoftwogroupswererecordedindetail,inordtoreorganizatandanalysisthedataaftertheexperimentFinally:Theoverallcurativeeffectoftreatmentgroupissuperiortothecontrolgroup,卩〈0.05,bothwasthesignificantdifference

5、?0ntheaspectofreducingbloodlipids,twogroupsweretheobviousdifferencebeforetreatment,P〈0?05;Butafterthetreatment,thechangesoftwogroup'sbloodlipidswerenotobviousdifferent?,P〉0?05;Ontheaspectofimprovementliverfunction,bothbloodserumALT,ASTwereobviousdifference,P〈0.05.Conclusion:TiaoZhiSoupcurative

6、effectissuperiortotheDongbaoLiverPieceobviouslyontreatthenon-alcoholicfattyliver?Itsmechanismistoreducethebloodlipidsandimprovelivercellfunctionpossibility?［Keyword】Thenon-alcoholicfattyliverdisease;TiaoZhiSoup非酒精性脂肪性肝病(NAFLD)是指除外酒精和其他明確的損肝因素所致的，以彌漫性肝細(xì)胞大泡性脂肪變?yōu)橹饕卣鞯呐R床病理綜合征，包括單純性脂肪肝以及由其演變的脂肪性肝炎(

7、NASH)和肝硬化。隨著肥胖和糖尿病的發(fā)病率增加，NAFLD現(xiàn)已成為我國(guó)常見的慢性肝病之一，嚴(yán)重危害人體健康［1］。筆者根據(jù)非酒精性脂肪肝的中醫(yī)病因病機(jī)特點(diǎn)，以調(diào)脂湯為主治療該病，取得較好療效，現(xiàn)報(bào)告如下：1臨床資料1.1一般資料162例非酒精性脂肪肝患者均為我院門診就診患者,隨機(jī)分為兩組，治療組81例,男57例，女24例;年齡21~68歲，平均(44?2±7?6)歲；病程0.5-15年。B超分級(jí)：輕度19人，中度19人，重度3人。對(duì)照組81例，男51例，女30例；年